Share this post on:

Product Name :
Labetuzumab govitecan

Search keywords :
CL2A

drugId :
null

Target Vo:
Carcinoembryonic antigen related cell adhesion molecule 5

Target Vo Short Name :
CEACAM5

Moa_Name:
Carcinoembryonic antigen related cell adhesion molecule 5 antagonists

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Immunomedics

Active Company_Name :

Active Indication_Name:

In Active Indication_Name:
Colonic Neoplasms

Termination Status :
Phase 2 Clinical

China Termination Status :

Highest Status:
Discontinued

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Hes1 Antibody
GRP78 BiP Antibody (YA746)
PTGES2 Antibody: PTGES2 Antibody is an unconjugated, approximately 43 kDa, rabbit-derived, anti-PTGES2 polyclonal antibody. PTGES2 Antibody can be used for: ELISA, IHC-P, IHC-F, Flow-Cyt, IF expriments in human, mouse, rat, and predicted: chicken, dog, pig, cow background without labeling.

Share this post on:

Author: Interleukin Related